Morgan Stanley
PKBO

Morgan Stanley’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Morgan Stanley’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-278
Closed -$1.17K – 8004
2022
Q4 		$1.17K Buy
+278
New +$1.93K ﹤0.01% 7451

Other funds holding PKBO

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Morgan Stanley's PKBO Position: Q1 2023 in Review

Morgan Stanley sold out of Peak Bio, Inc. Common Stock (PKBO) in Q1 2023, closing a stake of 278 shares — an estimated $1.17K sold.

Morgan Stanley first reported a position in PKBO in Q4 2022 and held it in 1 quarter. The position peaked at $1.17K in Q4 2022. 1 fund tracked by Wall St. Rank holds PKBO as of Q1 2023.

  • Morgan Stanley reported no remaining Peak Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 278 Peak Bio, Inc. Common Stock shares in Q1 2023, an estimated $1.17K.
  • Morgan Stanley first reported a position in Peak Bio, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Morgan Stanley's Peak Bio, Inc. Common Stock position peaked at $1.17K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.